David A. Klein

TL;DR: Adolescents and young women have high 12‐month continuation of long‐acting reversible contraceptive methods, and intrauterine devices and implants should be offered to all adolescents as first‐line contraceptive options.

TL;DR: Patients with early isolated pubertal changes, prepubertal linear growth, and no worrisome neurologic symptoms typically have a benign pattern of development and should be monitored in the appropriate clinical context, but among patients with true precocious puberty, or full activation of the hypothalamic-pituitary-gonadal axis, most girls have an idiopathic etiology, whereas it is commonly due to identifiable pathology on imaging in boys.

TL;DR: A systematic review of the medical literature to assess the continuation of long-acting reversible contraceptives among adolescents was performed in this paper, which included 12 studies, including 6 retrospective cohort studies, 5 prospective observational studies, and 1 randomized controlled trial.

TL;DR: Clinicians should identify and treat mental health conditions but avoid the assumption that such conditions are related to gender identity, and aspects of affirming care should not be delayed until gender stability is ensured.

TL;DR: Postpartum initiation of long‐acting reversible contraception is highly effective at the prevention of short interdelivery intervals, whereas pill, patch, or ring methods are associated with rates of shortinterference intervals similar to users of no prescription contraception.